NO20055948L - Rensing av HER-2 varianter - Google Patents

Rensing av HER-2 varianter

Info

Publication number
NO20055948L
NO20055948L NO20055948A NO20055948A NO20055948L NO 20055948 L NO20055948 L NO 20055948L NO 20055948 A NO20055948 A NO 20055948A NO 20055948 A NO20055948 A NO 20055948A NO 20055948 L NO20055948 L NO 20055948L
Authority
NO
Norway
Prior art keywords
provides
chromatography
variant
purification
variants
Prior art date
Application number
NO20055948A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Gregorius Nielsen
Marie Eskling
Original Assignee
Pharmexa As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmexa As filed Critical Pharmexa As
Publication of NO20055948L publication Critical patent/NO20055948L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20055948A 2003-06-25 2005-12-14 Rensing av HER-2 varianter NO20055948L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48231503P 2003-06-25 2003-06-25
DKPA200300954 2003-06-25
PCT/DK2004/000451 WO2004113377A1 (en) 2003-06-25 2004-06-24 Purification of her-2 variants

Publications (1)

Publication Number Publication Date
NO20055948L true NO20055948L (no) 2005-12-14

Family

ID=33542436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055948A NO20055948L (no) 2003-06-25 2005-12-14 Rensing av HER-2 varianter

Country Status (12)

Country Link
EP (2) EP2090586A1 (de)
JP (1) JP4579912B2 (de)
AT (1) ATE429447T1 (de)
AU (1) AU2004249362B2 (de)
CA (1) CA2530233C (de)
DE (1) DE602004020769D1 (de)
DK (1) DK1641819T3 (de)
ES (1) ES2325584T3 (de)
MX (1) MXPA05013389A (de)
NO (1) NO20055948L (de)
NZ (1) NZ544017A (de)
WO (1) WO2004113377A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763452B2 (en) 2003-06-25 2010-07-27 Bn Immunotherapeutics, Inc. Purification of HER-2 variants
WO2006102901A2 (en) * 2005-03-31 2006-10-05 Pharmexa A/S Immunogenic egfr peptides comprising foreign t cell stimulating epitope
DK2596801T3 (en) * 2006-10-06 2018-08-13 Bavarian Nordic As RECOMBINANT MODIFIED VACCINIA ANKARA VIRUS CODING A HER-2 ANTIGEN FOR USING CANCER TREATMENT
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
JP2023542867A (ja) 2020-09-11 2023-10-12 グリンプス バイオ， インコーポレイテッド 疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
SK4272001A3 (en) 1998-10-05 2003-02-04 Pharmexa As Methods for therapeutic vaccination
CZ20012587A3 (cs) * 1999-01-29 2002-05-15 Corixa Corporation Izolovaný protein, nukleová kyselina, virový vektor, farmaceutický prostředek, izolovaná populace T buněk, způsob posílení imunitní odpovědi, způsob odstranění nádorových buněk, způsob stimulace a/nebo namnoľení T buněk a způsob přípravy fúzního proteinu
WO2003087338A2 (en) * 2002-04-11 2003-10-23 Amgen, Inc. Her-2 receptor tyrosine kinase molecules and uses thereof

Also Published As

Publication number Publication date
EP1641819B1 (de) 2009-04-22
DE602004020769D1 (de) 2009-06-04
JP4579912B2 (ja) 2010-11-10
AU2004249362B2 (en) 2011-08-25
NZ544017A (en) 2008-04-30
AU2004249362A1 (en) 2004-12-29
CA2530233C (en) 2012-09-11
CA2530233A1 (en) 2004-12-29
EP2090586A1 (de) 2009-08-19
JP2007523615A (ja) 2007-08-23
EP1641819A1 (de) 2006-04-05
MXPA05013389A (es) 2006-03-17
ES2325584T3 (es) 2009-09-09
ATE429447T1 (de) 2009-05-15
DK1641819T3 (da) 2009-08-03
WO2004113377A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
EP1568710A3 (de) Reinigungsmethode für Antikörper
NO20063478L (no) Noytraliserende epitopebasert vekstfremmende vaksine
WO2008013454A3 (en) Immunogenic compounds and protein mimics
DK1553975T3 (da) Optimerede Fc-varianter og fremgangsmåder til generering heraf.
NO20071432L (no) Fremgangsmate for konsentrasjon av antistoffer of terapeutiske produkter derav.
WO2005016968A3 (en) Reducing protein a leaching during protein a affinity chromatography
WO2006041934A3 (en) Methods and compositions for improving recombinant protein production
WO2005118620A3 (en) Methods for preparing internally constraied peptides and peptidomimetics
DK1780269T3 (da) Virusrensningsmetoder
WO2006039563A3 (en) Method for providing dna fragments derived from an archived sample
ATE335852T1 (de) Happier mapping
WO2007130535A3 (en) Novel protein fusion/tag technology
DE602006019964D1 (de) Reinigung von montelukast
DK1675956T3 (da) Minimal DNA-sekvens, der virksom som chromatinisolator, og dennes anvendelse til proteinekspression
IL176522A0 (en) Universal amplification of fragmented rna
NO20055948L (no) Rensing av HER-2 varianter
WO2011090720A3 (en) Purification of proteins
EA200600102A1 (ru) Очистка вариантов her-2
ATE386823T1 (de) Marker-unterstützte rinderauswahl für verbesserte milchzusammensetzung
DE60314132D1 (de) Methode zur produktion monoklonaler antikörper
AR048651A1 (es) Proceso de amonolisis enzimatica para preparacion de compuestos intermediarios para inhibidores de dipeptidilo peptidasa iv
TW200506057A (en) Transient production of pharmaceutically important proteins in plants
ATE496993T1 (de) Transformierte saccharomyces cerevisiae sowie verfahren zur massenproduktion des proteins lk8 damit
ATE539085T1 (de) Verfahren zur isolierung von haptoglobin
TW200722435A (en) Purification of proteins with cationic surfactant

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application